loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Taladegib

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Taladegib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Endeavor BioMedicines Completes Enrollment in Phase 2a Clinical Trial of ENV-101
    Endeavor BioMedicines Completes Enrollment in Phase 2a Clinical Trial of ENV-101

    06 Sep 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230906375636/en

    BUSINESSWIRE
    06 Sep 2023
    Share Share
    Endeavor Doses First Patient in Phase 2 Oncology Study of ENV-101 (Taladegib)
    Endeavor Doses First Patient in Phase 2 Oncology Study of ENV-101 (Taladegib)

    25 May 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220525005283/en

    BUSINESSWIRE
    25 May 2022
    Share Share
    Endeavor Bio Closes $101M Series B Financing for Precision Medicine Pipeline
    Endeavor Bio Closes $101M Series B Financing for Precision Medicine Pipeline

    07 Feb 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220207005151/en

    BUSINESSWIRE
    07 Feb 2022
    Share Share
    Endeavor BioMedicines Doses First Patient in Phase 2 of Taladegib for IPF
    Endeavor BioMedicines Doses First Patient in Phase 2 of Taladegib for IPF

    22 Sep 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210922005035/en

    BUSINESSWIRE
    22 Sep 2021
    Share Share